Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Trial Designs Needed To Get Most Out Of CER, Duke's Califf Says

Executive Summary

A new clinical trial design is needed to ensure that the most value is extracted from investments being made in comparative effectiveness research in the U.S., Duke University Medical Center's Robert Califf said during a recent conference
Advertisement

Related Content

FDA's Califf On Real World Evidence: 'Use It For The Right Purposes'
Califf’s Trial Design Prescription: Less Randomization, More Transparency
Venture Capitalists Have A Growing Interest In Comparative Effectiveness
Venture Capitalists Have A Growing Interest In Comparative Effectiveness
Budget Continues AHRQ's Role As Leader On Comparative Effectiveness Work
Budget Continues AHRQ's Role As Leader On Comparative Effectiveness Work

Topics

Advertisement
UsernamePublicRestriction

Register

PS052141

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel